Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
ScanTech AI Systems Provides Update on Nasdaq Trading, Hearings Process, and Ongoing Restructuring Discussions
-
Jayud Expands U.S. Footprint with Strategic Warehouses in Southern California’s Premier Logistics Corridor
-
Vericel to Present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026
-
Ambiq Unveils Atomiq®, the World’s First Ultra-Low Power NPU SoC Built on SPOT®
-
Venture for ClimateTech Accelerator Launches Applications for Cohort 6
-
Syntec Optics (Nasdaq: OPTX) Wins New Order; Joins Industry Leaders to Enable US Military's Augmented Reality Systems Powered by Artificial Intelligence
-
Form 8.3 - [IQE PLC - 05 01 2026] - (CGAML)
-
Syntec Optics (Nasdaq: OPTX) Wins New Order; Joins Industry Leaders to Enable US Military's Augmented Reality Systems Powered by Artificial Intelligence
-
Viewbix: Quantum X Labs Announces Breakthrough in the Development of a Quantum Gyroscope Chip Technology
-
Publication of a Prospectus
-
Delaware Department of Transportation and TransCore Launch New Tolling Back Office System to Enhance Statewide Operations
-
Coeptis Therapeutics S-4 Declared Effective by SEC, Proxy Mailing Begins in Anticipation of the Merger Transaction with Z Squared
-
EAB Acquires Hybrid to Expand Global Reach and Enhance Digital Innovation
-
Nuwellis Announces Issuance of New U.S. Patent Supporting Advanced Safety Design for Pediatric Extracorporeal Therapy
-
Ernexa Therapeutics Announces Successful Pre-IND FDA Meeting and Continues Progress Toward First-in-Human Trial in Ovarian Cancer
-
24/7 Market News- Kraig Labs Breakthrough Science is Pivoting to Scalable Business
-
VivoSim Labs Appoints Amar Sethi, M.D., Ph.D. as Chief Scientific Officer
-
Treasure Global Concludes Alumni Capital Equity Line Facility to Streamline Capital Structure and Focus on Fintech & Digital-Asset Growth
-
Treasure Global Concludes Alumni Capital Equity Line Facility to Streamline Capital Structure and Focus on Fintech & Digital-Asset Growth
-
Stereotaxis Receives FDA Approval for MAGiC Ablation Catheter
-
Compass Therapeutics Provides Corporate Update
-
CG Oncology to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Syncromune Continues to Strengthen Executive and Clinical Leadership with Appointment of Dr. Stephen P. Dale, M.D., as Chief Medical Officer
-
Hallador Energy Appoints Barbara Sugg, Former CEO of Southwest Power Pool, to Join Board of Directors
-
Erasca to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Sparrow Pharmaceuticals Announces First Patient Enrolled in Phase 2b Clinical Trial Evaluating Clofutriben for Difficult-to-Control Type 2 Diabetes
-
Milestone Pharmaceuticals Announces Acceptance of Marketing Authorization Application for Etripamil Nasal Spray in PSVT by the European Medicines Agency
-
Skyworks Showcases Intelligent Connectivity Innovations at CES 2026
-
Sysco to Announce Second Quarter Fiscal Year 2026 Financial Results on January 27
-
BLAQclouds, Inc. Provides Update on BLAQclouds Property Group Spinout and Shareholder Verification Procedures
-
Maxus Mining Highlights Historical Polymetallic Results at the Quarry Project in British Columbia, Canada
-
Nic Pouches Announces New Seasonal Price Reduction and Mix and Match Offer on VELO Nicotine Pouches
-
CDT Environmental Technology Announces Private Placement of Common Stock
-
Vor Bio to Participate in the 44th Annual J.P. Morgan Healthcare Conference
-
Galecto Announces Key Additions to Leadership Team
-
Taysha Gene Therapies Announces Progress Across TSHA-102 Pivotal Gene Therapy Program in Rett Syndrome
-
The Chefs’ Warehouse, Inc. to Participate in the ICR Conference
-
Cerence AI to Participate in 28th Annual Needham Growth Conference
-
Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment effectiveness in patients with localized prostate cancer
-
Renewal Fuels, Inc. (OTC: RNWF) Releases Independent Harbinger Research Report Evaluating Kepler Fusion’s Texatron™ Platform
-
Akebia Therapeutics Announces First Patient Dosed in Phase 2 Clinical Trial of Praliciguat for the Treatment of Focal Segmental Glomerulosclerosis (FSGS)
-
SpyGlass Pharma Appoints Jean-Frédéric Viret as Chief Financial Officer
-
Cogent Biosciences Announces Presentation at the 44th Annual J.P. Morgan Healthcare Conference
-
Sow Good Inc. Announces $6.0 Million Private Placement, Strategic Asset Sale, and Leadership Transition to Support Continued Candy Operations and Future Growth
-
EllisDon Expands Mandatory Type 2 Head Protection to All On-Site Personnel
-
Remix Therapeutics Appoints Mythili Koneru, MD, PhD, as Chief Medical Officer
-
Picard Medical to Begin Rollout of FDA-Cleared Accessory for its SynCardia Total Artificial Heart
-
Totus Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
American Association of Critical-Care Nurses Selects Creative Health Care Insight as a Preferred Competency Management Provider
-
Seismic Therapeutic Announces Updated Presentation Time at the 44th Annual J.P. Morgan Healthcare Conference
